Financial News
J&J says its one-shot Covid vaccine is 72% effective in the U.S., but less potent in other regions
January 29, 2021 at 08:00 AM EST
The Covid vaccine was well tolerated, with no significant safety concerns related to the vaccine reported, J&J said. There were also no reports of anaphylaxis.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
